4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-070273
Director sold 755 shares at $30.25 ($22,839)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salter Malcolm Director | 2021-12-17 | Sale | −755 | $30.25 | $22,839 | 10,952 | D |
| Open-market sales · 755 sh · avg $30.25 · $22,839 | |||||||
Loading xslF345X03/doc4.xml…